Sign Up Today and Learn More About XWPharma Stock
Invest in or calculate the value of your shares in XWPharma or other pre-IPO companies through EquityZen's platform.
XWPharma Stock (XWPH)
XWPharma is a neuroscience biotech company that is researching new medicines for sleep, neuropsychiatric, and other neglected CNS illnesses.
About XWPharma Stock
Founded
2014
Headquarters
Redwood City, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
XWPharma Press Mentions
Stay in the know about the latest news on XWPharma
Modified release compositions of a gamma-hydroxybutyric acid derivative
patents • Apr 02, 2025
Compounds as nuclear transport modulators and uses thereof
patents • Apr 02, 2025
Compounds as neuronal histamine receptor-3 antagonists and uses thereof
patents • Apr 02, 2025
Pharmacokinetics of combined release formulations of a gamma-hydroxybutyric …
patents • Feb 12, 2025
Modified release compositions of a gamma-hydroxybutyric acid derivative
patents • Feb 12, 2025
XWPharma Management
Leadership team at XWPharma
Member Board of Directors
Asish Xavier
Head of Strategy, Program Management & Operations
William Xiang
Join now and verify your accreditation status to gain access to:
- XWPharma Current Valuation
- XWPharma Stock Price
- XWPharma Management
- Available deals in XWPharma and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- XWPharma Cap Table and Funding History by Share Class and Liquidity Preferences
- XWPharma Revenue and Financials
- XWPharma Highlights
- XWPharma Business Model
- XWPharma Risk Factors
- XWPharma Research Report from SACRA Research
Trading XWPharma Stock
How to invest in XWPharma stock?
Accredited investors can buy pre-IPO stock in companies like XWPharma through EquityZen funds. These investments are made available by existing XWPharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell XWPharma stock?
Shareholders can sell their XWPharma stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
